Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
Also known as: Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00002 | Cetuximab | 1 | Completed | 2 |
DB00515 | Cisplatin | 1 | Completed | 1 |
DB00515 | Cisplatin | 1 | Withdrawn | 1 |
DB01248 | Docetaxel | 1 | Completed | 1 |
DB12304 | Entolimod | 1 | Withdrawn | 1 |
DB01590 | Everolimus | 1 | Completed | 1 |
DB16555 | Lactoferrin | 1 | Terminated | 1 |
DB12303 | Motolimod | 1 | Completed | 1 |
DB00398 | Sorafenib | 1 | Completed | 1 |
DB11666 | Buparlisib | 1 / 2 | Completed | 1 |
DB00002 | Cetuximab | 1 / 2 | Completed | 1 |
DB09037 | Pembrolizumab | 1 / 2 | Completed | 1 |
DB02546 | Vorinostat | 1 / 2 | Completed | 1 |
DB11740 | Adavosertib | 2 | Terminated | 1 |
DB14235 | Bilberry | 2 | Withdrawn | 1 |
DB00188 | Bortezomib | 2 | Completed | 1 |
DB16741 | Bortezomib D-mannitol | 2 | Completed | 1 |
DB00002 | Cetuximab | 2 | Completed | 3 |
DB14547 | Chloride ion | 2 | Terminated | 1 |
DB00515 | Cisplatin | 2 | Terminated | 1 |
DB01254 | Dasatinib | 2 | Completed | 1 |
DB14240 | Echinacea | 2 | Withdrawn | 1 |
DB11680 | Ficlatuzumab | 2 | Completed | 1 |
DB00762 | Irinotecan | 2 | Completed | 1 |
DB06188 | Ispinesib | 2 | Completed | 1 |
DB04845 | Ixabepilone | 2 | Completed | 1 |
DB01259 | Lapatinib | 2 | Completed | 1 |
DB03010 | Patupilone | 2 | Completed | 1 |
DB12257 | Platinum | 2 | Terminated | 1 |
DB11805 | Saracatinib | 2 | Completed | 1 |
DB00398 | Sorafenib | 2 | Completed | 2 |
DB06287 | Temsirolimus | 2 | Completed | 1 |
DB00317 | Gefitinib | Not Available | Completed | 1 |